Anti-nMyc [NMYC-1]
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151136 |
| Applications | ChIP IHC IF IP WB EMSA |
| Antigen/Gene or Protein Targets | nMyc |
| Reactivity | Human |
| Relevance | Diagnosis and prognosis in childhood neuroblastoma. |
| Host | Mouse |
| Immunogen | Human N myc peptide sequence SPYVESEDAPPQKC conjugated to KLH. |
| Subclass | IgG2b |
| Myeloma Used | Sp2/0-Ag14 |
| Recommended Growing Conditions | RPMI 164O +10% FCS |
| Strain | Balb/c |
| Notes | This antigen is expressed in embryonic tissue and pre B cells, also found in neuroblastoma and small lung carcinoma. |
| Research Area | Cancer, Epigenetics & Nuclear Signalling |
References: 2 entries
Tasseva et al. 2011. J Biol Chem. 286(2):1061-73. PMID: 21068393.
ChIP EMSA
N-Myc and SP regulate phosphatidylserine synthase-1 expression in brain and glial cells.
Europe PMC ID: 21068393
Add a reference
References: 2 entries
Tasseva et al. 2011. J Biol Chem. 286(2):1061-73. PMID: 21068393.
ChIP EMSA
N-Myc and SP regulate phosphatidylserine synthase-1 expression in brain and glial cells.
Add a reference
